Fasting Mimicking Diet Reduces MS Symptoms and Promotes Remyelination: What the Research Shows

An Intermittent Fasting Diet Shifted Gut Bacteria and Improved Quality of Life in MS Patients: What the Research Shows

Fasting Mimicking Diet Reduces MS Symptoms and Promotes Remyelination: What the Research Shows

Medical disclaimer: This article summarises published research for informational purposes only. It is not medical advice and is not a substitute for guidance from a qualified health professional. Always consult your doctor before starting any fasting protocol, especially if you have an existing health condition or take medication.

Study at a Glance

What This Study Looked At

Multiple sclerosis (MS) is an autoimmune disease in which the immune system attacks the myelin sheath — the protective coating around nerve fibres — causing progressive neurological disability. This study asked whether a diet mimicking fasting (FMD) could reduce autoimmune inflammation, promote myelin repair, and improve quality of life in MS patients. The team at USC and Washington University used both a well-validated mouse model of MS and a human pilot randomised trial to answer this question. Fasting has been proposed as a way to reduce systemic inflammation and trigger cellular renewal — mechanisms directly relevant to autoimmune conditions.

Who Was Studied

Participant profile: Adults with confirmed relapsing-remitting multiple sclerosis (RRMS); no active disease modification restriction; able to follow dietary instructions.

How the FMD worked in this study: The fasting mimicking diet was a plant-based, very low-calorie protocol lasting 3 consecutive days per monthly cycle. Day 1 provided approximately 200–300 kcal from vegetable broths and plant juices. Days 2 and 3 provided slightly higher calories (~700–800 kcal) from specific soups and supplements. Participants did not fast completely — the FMD was designed to maintain the hormonal and metabolic effects of fasting while providing minimal nutrition. After the 3-day FMD window, participants returned to their normal eating pattern for the remainder of each month.

What the Researchers Found

Human Arm: Quality of Life and Safety

• The FMD was safe and feasible. No serious adverse events were recorded in any FMD participant across three monthly cycles.
• Quality of life improved significantly on the validated Multiple Sclerosis Impact Scale (MSIS-29) in the FMD group compared to controls — a clinically meaningful improvement on a patient-reported outcome widely used in MS trials.
• Lymphocyte counts decreased during the 3-day FMD period and then rebounded to baseline (or above baseline) after each cycle concluded — a pattern consistent with immune cell cycling and renewal.

Mouse Arm (EAE Model): Mechanistic Findings

The experimental autoimmune encephalomyelitis (EAE) mouse model closely mimics relapsing-remitting MS. The key findings were striking:

• FMD significantly reduced EAE clinical severity scores — mice on the FMD protocol had markedly less motor impairment and neurological disability than control mice.
• FMD promoted oligodendrocyte precursor cell (OPC) proliferation — OPCs are the cells responsible for generating new myelin. The FMD expanded this population, providing a cellular substrate for remyelination.
• Remyelination was documented histologically — FMD mice showed restoration of myelin in areas that had previously been demyelinated, a finding rarely seen in any dietary intervention.
• Neuroinflammation was reduced — fewer activated microglia (the brain's immune cells) and reduced pro-inflammatory cytokines in the central nervous system.
• Neural stem cell numbers increased — FMD promoted neurogenesis in the hippocampus, a region important for cognition.

What Did Not Change

• There were no significant changes in conventional neurological examination scores within the short 3-month human pilot period.
• The Mediterranean diet group showed some but generally smaller trends compared to FMD.

What the Researchers Concluded

The researchers concluded that the fasting mimicking diet was safe and well-tolerated in RRMS patients and showed promise for improving patient-reported quality of life over 3 monthly cycles. The preclinical data provided a compelling mechanistic rationale: FMD triggered immune cell cycling that may help reset dysregulated autoimmune responses, and — most remarkably — appeared to stimulate the regeneration of myelin, the damage to which underlies the progression of MS.

What This Means If You Fast

• Immune cell cycling may be a feature, not a bug. The temporary drop in lymphocyte counts during the FMD followed by a rebound mirrors what is seen in other forms of short-term fasting and may represent a form of immune "reset" — potentially beneficial in conditions where the immune system attacks the body's own tissues.
• Short periodic fasts may be more relevant than daily IF for autoimmune conditions. The FMD protocol used here (3 days/month) is different from standard 16:8 daily intermittent fasting. For autoimmune conditions, the periodic multi-day approach appears to drive the most significant immune and cellular changes.
• Neuroinflammation reduction is a plausible mechanism. The consistent finding that fasting reduces inflammation is directly relevant to brain health and conditions driven by neuroinflammation.
• Myelin regeneration is a potentially transformative finding. Most MS treatments work by suppressing the immune attack; this research suggests fasting protocols may additionally stimulate repair — a fundamentally different and complementary mechanism.
• This should not replace disease-modifying therapies. The human arm was a small pilot. Anyone with MS considering dietary interventions must work closely with their neurologist.
• The FMD calorie threshold matters. The protocol used in this study was specifically designed to maintain a fasting hormonal state while providing minimal nutrition. Reducing calories modestly is not the same as an FMD — the threshold matters.

Study Limitations

• The human arm was an open-label pilot (neither participants nor assessors were blinded) — a significant limitation for interpreting patient-reported outcomes
• Small sample size in the human arm (~20 per group) limits statistical power and generalisability
• Short duration (3 months) — long-term effects on MS progression are unknown from this study
• The primary mechanistic finding (remyelination) was demonstrated in a mouse model, not in humans
• Self-reported quality of life as the primary human outcome is subject to placebo and expectation effects
• Only relapsing-remitting MS was studied — results may not apply to progressive MS variants
• Funding from the National MS Society and Italian MS Association; no commercial pharmaceutical conflicts disclosed, but the FMD protocol itself has been developed commercially

Source

Choi IY, Piccio L, Childress P, Bollman B, Ghosh A, Brandhorst S, Suarez J, Mickanin C, McKnight D, Le Beau MM, Yassine HN, Agrawal M, Shayeganmehr A, Bhupinder B, Longo VD. A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms. Cell Reports. 2016;15(10):2136–2146. PMID: 27239027

Frequently Asked Questions

Can a fasting mimicking diet help with multiple sclerosis?

This 2016 pilot study found that a 3-day monthly FMD improved quality of life in RRMS patients and caused no serious adverse events. The most compelling data came from mouse models, where the FMD reduced disease severity and promoted myelin regeneration. This research is promising but preliminary — the human arm was small and open-label. Anyone with MS should discuss any dietary change with their neurologist.

What is a fasting mimicking diet (FMD)?

An FMD is a plant-based, very low-calorie dietary protocol lasting 3–5 days that is designed to trigger the metabolic and cellular effects of a complete fast while providing some minimal nutrition. In the Choi 2016 study, the FMD provided approximately 200–800 kcal per day depending on the day in the cycle. This is distinct from standard intermittent fasting protocols like 16:8, which restrict the eating window daily.

How does fasting affect the immune system in MS?

The main observed effect in both humans and mice was a decrease in lymphocyte counts during the FMD period, followed by a rebound after the fast ended. This immune cell cycling is thought to clear damaged or dysregulated immune cells and allow a healthier population to repopulate — potentially reducing the autoimmune attack on myelin.

Can fasting help repair the myelin sheath?

In the mouse model of MS used in this study, the FMD protocol promoted proliferation of oligodendrocyte precursor cells (the cells that create myelin) and resulted in documented myelin regeneration. This has not yet been confirmed in human studies, but it is one of the most significant findings in fasting and neurological health research to date.

Is intermittent fasting safe for people with multiple sclerosis?

The human pilot in this study showed the 3-day monthly FMD was safe and well-tolerated, with no serious adverse events. However, MS is a complex condition and fasting affects fatigue, energy, and medication absorption. People with MS should only modify their diet under medical supervision. Extended fasting or very low calorie protocols may not be appropriate for all MS patients, particularly those with significant disability or on complex medication regimens.

Related Research and Articles

• Intermittent fasting and inflammation: the research explained
• Intermittent fasting and brain health: the neuroscience
• How intermittent fasting promotes autophagy
• Fasting and immune system regeneration (Cell Stem Cell 2014)
• Intermittent fasting and longevity: what the science says
• Does intermittent fasting slow aging?
• Fasting and inflammation: what women should know

Want the complete guide to fasting? Get Intermittent Fasting in Practice on Amazon — and claim 3 months free on our fasting app at fastinginpractice.com/redeem.